[1]
Nayak, S.K., Khatik, G.L., Narang, R. and Chopra, H.K. 2017. DESIGN AND ANTICANCER ACTIVITY PREDICTION OF DIHYROPYRIMIDINONE BASED NOVEL INHIBITORS OF P53-MDM2 INTERACTION. Asian Journal of Pharmaceutical and Clinical Research. 10, 16 (Sep. 2017), 110–116. DOI:https://doi.org/10.22159/ajpcr.2017.v10s4.21346.